Our Services
Medical Information
Helpful Resources
Published on: 8/18/2026
Mass spectrometry identifies substances by measuring the exact mass of their molecular fragments, giving it far greater accuracy than the rapid immunoassay screens used in many routine labs. That precision matters because immunoassays can flag the wrong compound, producing false positives from common medications, supplements, or foods, while specialized confirmatory testing distinguishes look-alike molecules and reduces misdiagnosis, unnecessary treatment, and wrongful accusations. Turnaround time, cost, sample handling, and the specific method used (such as LC-MS/MS versus GC-MS) all influence how reliable a result really is, and there are several important factors to consider. See below to understand the details that determine whether a result should be confirmed before acting on it.
If you are questioning a lab result or trying to make sense of symptoms that prompted testing in the first place, a free, instant, online symptom check can help you organize what you are experiencing, see which conditions may fit the pattern, and walk into your next appointment ready to ask whether confirmatory testing is warranted.
Last reviewed for medical accuracy: 08/18/2026
Accurate laboratory testing is the cornerstone of effective diagnosis and treatment. When it comes to measuring vitamin levels, hormones or complex drugs in the blood, even small errors can lead to misdiagnosis or inappropriate therapy. Mass spectrometry, especially liquid chromatography–tandem mass spectrometry (LC-MS/MS or LC MS MS), has emerged as the gold standard for many assays. In particular, Serum 25 hydroxyvitamin D testing accuracy LC MS MS illustrates why specialized lab methods matter.
Mass spectrometry (MS) is an analytical technique that measures molecules by converting them into charged particles, separating them based on mass-to-charge ratio, and detecting them. When coupled with liquid chromatography (LC), the combined LC-MS/MS system offers:
LC-MS/MS (also written LC MS MS) typically involves two stages of mass analysis. The first MS isolates a target ion; the second MS fragments it and analyzes the pieces. This “tandem” approach provides a molecular fingerprint, reducing the risk of interference.
Many labs still rely on immunoassays for routine analytes like vitamin D, thyroid hormones or certain drugs. While immunoassays are convenient and high-throughput, they have drawbacks:
These issues can lead to under- or overestimation of actual concentrations, affecting clinical decisions.
Specialized labs equipped with LC-MS/MS systems implement rigorous protocols to ensure accuracy:
Chromatographic Separation
• Separates analytes from interfering substances
• Resolves isobaric compounds (same molecular weight but different structures)
Stable Isotope–Labeled Internal Standards
• Chemically identical to the target analyte but heavier
• Correct for losses during sample prep and signal variation
Method Validation and Calibration
• Extensive validation over the clinically relevant range
• Use of certified reference materials to establish traceability
Quality Control and Proficiency Testing
• Daily quality control (QC) samples at low, medium and high levels
• Participation in external proficiency testing programs
Lower Detection Limits
• Detects analytes at very low concentrations
• Critical for early detection or monitoring therapy
Vitamin D status is assessed by measuring 25-hydroxyvitamin D [25(OH)D] in serum. Common pitfalls of immunoassays include:
In contrast, LC-MS/MS offers:
A comparison of assay performance shows:
| Feature | Immunoassay | LC-MS/MS |
|---|---|---|
| Specificity | Moderate (cross-reactivity risk) | Very high (tandem fragmentation) |
| Distinguishes D2 vs. D3 | Often cannot | Yes |
| Sensitivity | ~5–10 ng/mL | ~1–2 ng/mL |
| Reagent variability | Higher | Minimal (stable isotopes standardize) |
| Interference from other compounds | More likely | Rare |
Because of these advantages, major clinical guidelines now recommend LC-MS/MS for reference 25(OH)D measurements and for labs seeking the highest accuracy.
Specialized laboratories follow stringent protocols:
These measures combine to reduce analytical variation to less than 5%, compared with 10–15% in many routine assays.
Why does this matter to you or your healthcare provider?
If you’ve had a serum 25-hydroxyvitamin D test by an immunoassay and your clinical picture doesn’t match (symptoms persist despite “normal” levels), ask your clinician whether an LC-MS/MS–based assay is available.
Remember, timely and accurate lab results guide better decisions and outcomes.
Laboratory tests are one piece of the puzzle. Always:
By understanding the science behind mass spectrometry and choosing specialized lab testing when appropriate, you can help ensure your care is based on the most accurate information available.
(References)
* Fearing MK, Levy HL. Expanded newborn screening using tandem mass spectrometry. Adv Pediatr. 2003;50:81-111. PMID: 14626484.
* Lippi G, Daves M, Mattiuzzi C. Interference of medical contrast media on laboratory testing. Biochem Med (Zagreb). 2014;24(1):80-8. doi: 10.11613/BM.2014.010. Epub 2014 Feb 15. PMID: 24627717; PMCID: PMC3936969.
* Kim MS, Zhong J, Pandey A. Common errors in mass spectrometry-based analysis of post-translational modifications. Proteomics. 2016 Mar;16(5):700-14. doi: 10.1002/pmic.201500355. PMID: 26667783; PMCID: PMC5548100.
* El-Farhan N, Rees DA, Evans C. Measuring cortisol in serum, urine and saliva - are our assays good enough? Ann Clin Biochem. 2017 May;54(3):308-322. doi: 10.1177/0004563216687335. Epub 2017 Mar 16. PMID: 28068807.
* Poonawala H, Marrs Conner T, Peaper DR. The Brief Case: Misidentification of Brucella melitensis as Ochrobactrum anthropi by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry (MALDI-TOF MS). J Clin Microbiol. 2018 Jun;56(6). doi: 10.1128/JCM.00914-17. Epub 2018 May 25. PMID: 29802238; PMCID: PMC5971538.
* Chen F, Ye Y, Jin B, Yi B, Wei Q, Liao L. Homicidal Paraquat Poisoning. J Forensic Sci. 2019 May;64(3):941-945. doi: 10.1111/1556-4029.13945. Epub 2018 Nov 19. PMID: 30452771.
* Moore LM, Cho S, Thoren KL. MALDI-TOF mass spectrometry distinguishes daratumumab from M-proteins. Clin Chim Acta. 2019 May;492:91-94. doi: 10.1016/j.cca.2019.02.017. Epub 2019 Feb 18. PMID: 30790545; PMCID: PMC6524149.
* McLaughlin J, Burnham CD, McDowell A. MALDI-TOF mass spectrometry misidentification of Cutibacterium namnetense and Cutibacterium modestum: Implications for multiplex PCR phylotyping of Cutibacterium acnes. Anaerobe. 2024 Aug;88:102874. doi: 10.1016/j.anaerobe.2024.102874. Epub 2024 Jun 6. PMID: 38848934.
* Howley F, Abukhodair S, de Barra E, O'Connell K, McNally C. Misidentification of Brucella melitensis as Ochrobactrum species: potential pitfalls in the diagnosis of brucellosis. BMJ Case Rep. 2024 Jun 19;17(6). doi: 10.1136/bcr-2024-260072. Epub 2024 Jun 19. PMID: 38901850.
* Saitman A, Fitzgerald RL, Lund K, Suhandynata RT, Menlyadiev M. False positive urine drug screens. J Anal Toxicol. 2026 May 23;50(4). doi: 10.1093/jat/bkag007. PMID: 41639014.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.